analyst
OB
NASDAQ · OBIO
Orchestra BioMed Holdings, Inc.
Healthcare · Biotechnology
$6.08
Up+$0.30 (+5.19%)
Updated Sep 19, 2026, 8:12 PM
SID Score
6.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 257.76M
- P/E ratio
- -2.51
- Dividend yield
- 0.00%
- 52-week range
- $2.20 – $6.28
- Volume
- 1.14M
- Avg. volume
- 309.78K
Price performance
OBIO price history
1M range · 20 trading sessions · Daily adjusted prices
OBIO closed at $6.08 after 20 trading sessions, up 13.43% for the selected period.
- Last close
- $6.08
- Period change
- +13.43%
- Period low
- $4.74
- Period high
- $6.12
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $5.74 | $6.30 | $5.71 | $6.08 | 1.14M |
| Sep 17, 2026 | $6.03 | $6.26 | $5.73 | $5.78 | 411.8K |
| Sep 16, 2026 | $6.05 | $6.28 | $5.93 | $6.01 | 297.2K |
| Sep 15, 2026 | $6.00 | $6.13 | $5.93 | $6.04 | 228.74K |
| Sep 14, 2026 | $6.07 | $6.20 | $5.74 | $5.90 | 383.62K |
| Sep 11, 2026 | $5.87 | $6.25 | $5.7604 | $6.12 | 464.46K |
| Sep 10, 2026 | $5.845 | $6.08 | $5.68 | $5.81 | 761.62K |
| Sep 9, 2026 | $5.31 | $5.4599 | $5.2609 | $5.45 | 198.56K |
| Sep 8, 2026 | $5.18 | $5.51 | $4.80 | $5.43 | 359.34K |
| Sep 4, 2026 | $4.71 | $5.14 | $4.71 | $5.08 | 478.14K |
| Sep 3, 2026 | $4.97 | $4.97 | $4.71 | $4.74 | 325.59K |
| Sep 2, 2026 | $4.92 | $5.01 | $4.83 | $4.95 | 240.38K |
| Sep 1, 2026 | $5.02 | $5.3492 | $4.875 | $4.90 | 214.52K |
| Aug 31, 2026 | $5.23 | $5.33 | $5.0037 | $5.04 | 276.55K |
| Aug 28, 2026 | $5.23 | $5.23 | $5.06 | $5.185 | 154.46K |
| Aug 27, 2026 | $5.23 | $5.4199 | $5.10 | $5.11 | 220.53K |
| Aug 26, 2026 | $5.36 | $5.45 | $5.16 | $5.26 | 391.71K |
| Aug 25, 2026 | $5.37 | $5.50 | $5.35 | $5.36 | 169.6K |
| Aug 24, 2026 | $5.35 | $5.48 | $5.21 | $5.44 | 249.53K |
| Aug 21, 2026 | $5.45 | $5.53 | $5.27 | $5.36 | 276.67K |
Latest OBIO news
The latest Smart Investors Daily articles mentioning OBIO.
Stock researchCompany · Financials
Loading stock research…

